Geovax Labs trades -3.29 percent lower on Monday 26th of October
Geovax Labs stock dips 3.3% as investors weigh its 2026 biotech potential and low $0.19 price, amid a 52‑week range of $0.20–$15.18.
- GEOVAX LABS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read